by Joan Arehart-Treichel
Psychiatric News | March 20, 2014
While clinical applications of genetic findings relevant to psychiatric disorders are still in their infancy, the field abounds with possibilities.
Oxford University Press | March 1, 2014
Read the first issue of the Journal of Law and the Biosciences, “the first fully Open Access peer-reviewed legal journal focused on the advances at the intersection of law and the biosciences.” The journal is a co-venture between Duke University, Harvard University Law School, and Stanford University, and is published by Oxford University Press.
National Core for Neuroethics | February 24, 2014
On Wednesday March 12, there will be a panel discussion on how information about our brains is being stored and used today. The event takes place from 6:30-8:30pm at the Wosk Centre for Dialogue in Vancouver, and is part of the Brain Matters! Vancouver International Conference. Admission is free, but registration is required.
by Dirk Hanson
The Dana Foundation | January 23, 2014
Have we tipped too far in considering addiction a disease of only the brain, with no reference to the outside world? Some addiction researchers say yes.
by Bethany Brookshire
The Blog of the Presidential Commission for the Study of Bioethical Issues | December 18, 2013
In its review of ethical issues in neuroscience, the Bioethics Commission will "'consider how best to integrate ethics into neuroscience broadly–and the BRAIN Initiative specifically– but this Bioethics Commission will not be the ultimate locus of that integration.'"
by Daniel Freeman
The Guardian | December 13, 2013
Supposed differences between the brains of men and women are uncritically reported, while a very real disparity is ignored.
by Kayt Sukel
The Dana Foundation | December 12, 2013
Defendants are “blaming the brain” not only to mitigate sentences after conviction, but in their defense, of crimes from homicide to fraud. At the recent Society for Neuroscience annual meeting, Nita Farahany described the types of cases where neuro-evidence is already being used.
by Julie Haas
NeuroeEthics Women Leaders | December 12, 2013
A recap of the Science and Ethics of Moral Enhancement panel at November’s International Neuroethics Society meeting in San Diego.
See also
by Maggie Fox
NBC News | November 25, 2013
The FDA orders gene-testing company 23andMe to stop illegally selling its tests to diagnose disease.
by Andrew Kahn
Dana Foundation Blog | November 12, 2013
Panelists at an International Neuroethics Society event tackled complex and difficult questions about treating patients in a vegetative or minimally conscious state.
See also
by Ann Whitman
Dana Foundation Blog | November 10, 2013
Panelists at the International Neuroethics Society meeting weighed in on the questions: Can we create a morality pill? And if we can, should we?
See also
by Andrew Kahn
Dana Foundation Blog | November 8, 2013
Neurogaming was the topic at the International Neuroethics Society public program.
Page: 1 of 13